Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001641172-25-020253
Filing Date
2025-07-18
Accepted
2025-07-18 16:49:26
Documents
14

Document Format Files

Seq Description Document Type Size
1 S-1/A forms-1a.htm S-1/A 476665
2 EX-23.1 ex23-1.htm EX-23.1 3235
3 CALCULATION OF FILING FEE TABLES ex107.htm   iXBRL EX-FILING FEES 28474
4 GRAPHIC forms-1_001.jpg GRAPHIC 5062
  Complete submission text file 0001641172-25-020253.txt   643004

Data Files

Seq Description Document Type Size
16 EXTRACTED XBRL INSTANCE DOCUMENT ex107_htm.xml XML 7083
Mailing Address 217 W. MAIN STREET SOMERVILLE NJ 08876
Business Address 217 W. MAIN STREET SOMERVILLE NJ 08876 908-370-5102
ZyVersa Therapeutics, Inc. (Filer) CIK: 0001859007 (see all company filings)

EIN.: 862685744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-288470 | Film No.: 251135020
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)